Description

Ethyl 3-(Hydroxymethyl)-4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4,5]Decane-8-Carboxylate is a sophisticated spirocyclic organic compound that serves as a critical building block in advanced chemical synthesis. Its unique molecular architecture, featuring a spiro center and multiple functional groups, makes it a versatile intermediate for constructing complex pharmacologically active molecules. This high-purity intermediate is essential for research and development chemists in the pharmaceutical and agrochemical industries seeking to develop new active ingredients.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its complex heterocyclic structure.
• Chemical Biology Probe Synthesis: Employed to create specialized molecular tools for studying biological pathways and protein interactions.
• Organic Synthesis Building Block: Utilized in academic and industrial R&D for constructing complex nitrogen-containing heterocycles and spiro compounds.
• Material Science Research: Investigated as a potential monomer or additive for creating specialty polymers with unique properties.

Basic Information

Product Name	Ethyl 3-(Hydroxymethyl)-4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4,5]Decane-8-Carboxylate
CAS No.	83863-45-0
Molecular Formula	C₁₇H₂₁N₃O₄
Molecular Weight	331.37 g/mol
Synonyms	Ethyl 3-(hydroxymethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxylate; 1-Phenyl-3,8-diazaspiro[4.5]decane-8-carboxylic acid, 3-(hydroxymethyl)-4-oxo-, ethyl ester; 83863-45-0; Ethyl 1-phenyl-3,8-diazaspiro[4.5]decane-8-carboxylate-3-methanol-4-one; Spiro[4.5]decane-8-carboxylic acid derivative
EINECS	Contact for details

Quality Control

Our Ethyl 3-(Hydroxymethyl)-4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4,5]Decane-8-Carboxylate is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research and scale-up applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP guidelines where applicable, and our quality protocols are designed to meet the stringent requirements of pharmaceutical development partners.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.